Global Med Technologies(R), Inc. Announces Second Sub-Sahara Africa SafeTrace(R) Software Installation
January 28 2005 - 10:00AM
PR Newswire (US)
Global Med Technologies(R), Inc. Announces Second Sub-Sahara Africa
SafeTrace(R) Software Installation DENVER, Jan. 28
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a
division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN
BOARD: GLOB) ("Global Med" or the "Company"), announced the second
African blood center to install its SafeTrace(R) donor management
system. Global Med's placement of its products in sub-Sahara Africa
and other international markets has the potential to help
underdeveloped countries upgrade and secure their blood supplies.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Blood centers in underdeveloped countries face challenges beyond
those in technologically advanced countries. Blood shortages are a
concern; however, the blood supply is at a greater risk of possible
contamination with blood-borne diseases, such as HIV, hepatitis,
syphilis, etc. The spread of HIV, in particular, has become the
driving force behind the current initiatives to improve the
environment in which blood is collected and tested, which may in
turn help to decrease the transmission rate of HIV/AIDS through
blood transfusions in these countries. Replacing their manual
processes and manual records with automated solutions can help to
manage their donor testing and help to ensure the safe release of
blood and blood products for transfusion. Will Willman, Senior Vice
President of International Business Development stated, "We were
able to provide a relatively low cost solution that is suited to
the technologically challenged African environment in a relatively
short period of time. Data that is entered by the blood center
staff in Africa is transmitted securely via satellite to a data
center located in Denver, Colorado. The staff at this data center
provides all of the computer system support including database
management and monitoring thereby greatly reducing the complexity
and cost of providing this solution for a blood center in Africa."
Mr. Willman added, "The quality of our products and the competency
of our employees provide the foundation for future installations in
the international markets." This second sub-Saharan installation
marks the beginning of the potential installation of our products
in other countries in Africa and other international countries. The
international market affords a $100+ million dollar potential for
Global Med Technologies and we look forward to fulfilling this
opportunity." About Global Med Technologies, Inc. Global Med
Technologies, Inc. is an international e-Health, medical
information technology company, providing information management
software products and services to the healthcare industry. Its
Wyndgate Technologies division is a leading supplier of information
management systems to U.S. and international blood centers and
hospital transfusion centers. Current clients of Wyndgate's
products and services manage more than 3 million units of blood, or
over 22% of the U.S. blood supply, each year. Wyndgate's products
are also being implemented in Canada, the Caribbean and sub-Sahara
Africa. Together, the SafeTrace donor management system and the
SafeTrace Tx(R)* advanced transfusion management system provide
Vein-to-Vein(R) tracking from donor collection to patient
transfusion. For more information about Global Med's products and
services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Press, Wm. Scott Dustin, Vice President of Sales and
Marketing, +1-916-404-8415, , or Investors, Tom Marcinek, President
and COO, +1-916-404-8413, , both of Wyndgate Technologies Web site:
http://www.globalmedtech.com/
Copyright